Empagliflozin ameliorates RSL3-induced ferroptosis in vascular endothelial cells via the NRF2/HO-1 pathway

Abstract Endothelial cell dysfunction is a fundamental injury of atherosclerosis cardiovascular disease (ASCVD), closely linked to ferroptosis, which is a novel type of cell death induced by iron-dependent lipid peroxidation. Several clinical trials have suggested that empagliflozin, a selective inh...

ver descrição completa

Detalhes bibliográficos

Principais autores:	ZiLin Wang, SiMiao Liu, JiaHao Shi, Di Chen, ShaoLin Li, ShengQin Yu, SiXu Liu, KaiJing Yang, Wan Zhang, Xue Gao, ShuYing Zhang
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-06-01
Colecção:	BMC Cardiovascular Disorders
Assuntos:	Empagliflozin Ferroptosis Endothelial cell injury NRF2 HO-1
Acesso em linha:	https://doi.org/10.1186/s12872-025-04890-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!